𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles

✍ Scribed by Samira Rasaneh; Hossein Rajabi; Mohammad Hossein Babaei; Shahram Akhlaghpoor


Publisher
Springer Netherlands
Year
2010
Tongue
English
Weight
427 KB
Volume
13
Category
Article
ISSN
1388-0764

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


MR molecular imaging of the Her-2/neu re
✍ Dmitri Artemov; Noriko Mori; Baasil Okollie; Zaver M. Bhujwalla πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 610 KB

MR molecular imaging is an exciting new frontier in the biomedical applications of MR. One of the clinically relevant targets is the tyrosine kinase Her-2/neu receptor, which has a significant role in staging and treating breast cancer. In this study Her-2/neu receptors were imaged in a panel of bre

MR imaging of the her2/neu and 9.2.27 tu
✍ Martin A Funovics; Barbara Kapeller; Christoph Hoeller; Henry S Su; Rainer Kunst πŸ“‚ Article πŸ“… 2004 πŸ› Elsevier Science 🌐 English βš– 400 KB

Molecular imaging of tumor antigens using immunospecific magnetic resonance (MR) contrast agents is a rapidly evolving field, which can potentially aid in early disease detection, monitoring of treatment efficacy, and drug development. In this study, we designed, synthetized, and tested in vitro two

Investigation of the magnetic properties
✍ D. Pouliquen; H. Perroud; F. Calza; P. Jallet; J. J. Le Jeune πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 756 KB

## Abstract Superparamagnetic iron oxide particles, a new class of contrast agents for MRI, are extremely good enhancers of proton relaxation. However, the development of such particle systems has resulted in a wide range of preparations whose physico‐chemical properties differ greatly. We have con

PAMAM dendrimer-based contrast agents fo
✍ Wenlian Zhu; Baasil Okollie; Zaver M. Bhujwalla; Dmitri Artemov πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 679 KB

## Abstract Pretargeting of receptors is a useful approach in molecular imaging and therapy to reduce background noise or toxicity and enhance selectivity. In this study a three‐step pretargeting approach that includes a biotinylated antibody, avidin/streptavidin, and a biotinylated imaging agent i